Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In March 2011, the FDA placed the trial on clinical hold due to GMP compliance issues at the contract manufacturer not safety concerns with RGN-352 itself
The company behind AOD-9604 knew back in 2007, after six clinical trials of 925 patients, that the drug had completely failed to treat obesity
Researchers continue to investigate how NNMT inhibition may alter cellular metabolic processes and affect broader physiological systems involved in metabolic health
For example, it is illegal to drive a car if you have a blood-alcohol content of over 0.08%
US$ 22.61
.png)
US$ 29.12
US$ 21.53
:max_bytes(150000):strip_icc()/Health-Stocksy-5080005-bb10491e0de9443eb957e3b7ecd8ef27.jpg)
US$ 22.33
